Skip to main content
Log in

Possible effect of subclinical inflammation on daily life in familial Mediterranean fever

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study was performed to investigate the attack-free complaints of patients with familial Mediterranean fever (FMF) and the impact of colchicine on these symptoms and on subclinical inflammation. A questionnaire that includes information about the disease course and symptoms during the attack-free period was administered to the parents of 50 FMF patients. For evaluation of the attack-free period, questions were asked about four items concerning daily activities of the children—weakness, lack of appetite, sleep problems, and decreased activity. The respondents rated the items and the total score was taken as the sum of all of the specific items. The laboratory values were noted from the patients’ files. During the attack-free period, patients with mild disease had higher total scores, higher weakness, and decreased activity scores than patients with moderate disease. When we compared the daily activity scores before and after colchicine therapy, a statistically significant increase was observed in the total scores and in all of the specific item scores. Also a significant decrease was seen in the erythrocyte sedimentation rate and white blood cell counts, and a significant increase was seen in the hemoglobin levels during the attack-free period after colchicine usage. Regression of inflammation together with improvement in daily activities were observed. FMF patients seem to have complaints during the attack-free period that may be related to subclinical inflammation. Moreover, colchicine besides preventing the FMF attacks and the dangerous complication ol amyloidosis also seems to hinder the symptoms of the attack-free period in children with FMF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253

    Article  PubMed  CAS  Google Scholar 

  2. Yalçinkaya F, Turner N, Tekin M, Çakar N, Akçakus M (1997) Familial Mediterranean fever in Turkish children (analysis of 110 cases). In: Sohar E, Gafni J, Pras M (eds) First International Conference on Familial Mediterranean Fever (FMF) (abstract book). Freund Publishing House, London, pp 157–161

    Google Scholar 

  3. The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31

    Article  Google Scholar 

  4. Majeed HA, Rawashdeh M, El-Shanti H, Quabain H, Khuribulos N, Shahin HM (1999) Familial Mediterranean fever in children: the expanded clinical profile. Q J Med 92:309–318

    CAS  Google Scholar 

  5. Goldfinger SE (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287:1302

    PubMed  CAS  Google Scholar 

  6. Özkan E, Okur Ö, Ekmekçi A, Özcan R, Tag T (1972) A new approach to the treatment of periodic fever. Med Bull Istanbul 5:44–49

    Google Scholar 

  7. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934

    Article  PubMed  CAS  Google Scholar 

  8. Zemer D, Livneh A, Danon YL, Pras M, Sohar E (1991) Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 34:973–977

    Article  PubMed  CAS  Google Scholar 

  9. Ben-Chetrit E, Levy M (1991) Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum 20:241–246

    Article  PubMed  CAS  Google Scholar 

  10. Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659–664

    Article  PubMed  CAS  Google Scholar 

  11. Tunca M, Kirkali G, Soytürk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response and evolution of familial Mediterranean fever. Lancet 353:1415

    Article  PubMed  CAS  Google Scholar 

  12. Korkmaz C, Özdogan H, Kasapçopur Ö, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81

    Article  PubMed  CAS  Google Scholar 

  13. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885

    Article  PubMed  CAS  Google Scholar 

  14. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Establishment of a new set of criteria for the classification of familial Mediterranean fever. In: Sohar E, Gafni J, Pras M (eds) First international conference on familial Mediterranean fever (FMF) (abstract book). Freund Publishing House, London, pp 203–208

    Google Scholar 

  15. Özkaya N, Yalçinkaya F (2003) Colchicine treatment in children with familial Mediterranean fever. Clin Rheumatol 22:314–317

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Z. Birsin Özcakar.

Additional information

Published online: 20 September 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Özcakar, Z.B., Yalçinkaya, F., Yüksel, S. et al. Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol 25, 149–152 (2006). https://doi.org/10.1007/s10067-005-1148-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-1148-z

Keywords

Navigation